Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News (Part 2 of 2)

The world's largest contract research organization, Quintiles Transnational has been operating in Asia-Pacific for more than 17 years. Two Asia-based executives, Quintiles India CEO Dr. Ferzaan Engineer and Senior VP and Head of Clinical Development for Quintiles Asia-Pacific Dr. Mr. Tharmaratnam recently shared their views with PharmAsia News on the changing CRO landscape in Asia. In part one of the interview, they talked about clinical research and development trends in the region, and opportunities and challenges for multinational CROs operating in China.